Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 CNS 1

Conditions

Interventions

Temozolomide 166 Magnetic Resonance Spectroscopy 131 Radiotherapy 97 Specimen Handling 81 Radiosurgery 61 Cyclophosphamide 56 pembrolizumab 52 Bevacizumab 52 Radiation 48 Nivolumab 48 Carboplatin 36 Biopsy 33 Irinotecan 29 Etoposide 25 Vincristine 24 Lomustine 24 Topotecan 23 Ipilimumab 23 Blood Specimen Collection 23 Cisplatin 22 dinutuximab 21 fludarabine 19 Surgical Procedures, Operative 19 Radiotherapy, Intensity-Modulated 19 X-Rays 18 abemaciclib 16 Mental Status and Dementia Tests 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 Pemetrexed 15 atezolizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Escitalopram × CNS × 1 year × Clear all

NCT03728673 2026-04-17

A Study Utilizing Escitalopram in Glioma Patients

University of Nebraska

Phase 2 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡